Tricyclic Antidepressants Screen, Urine
Use
The Tricyclic Antidepressants Screen, Urine is used for the preliminary screening for the presence of tricyclic antidepressants in urine. This test can be used in the clinical management of patients to detect potential overdose or therapeutic monitoring where tricyclic antidepressants are involved.
Special Instructions
This assay provides a preliminary unconfirmed analytical test result that is not suitable for forensic purposes without confirmation. For workplace drug testing, positive findings should be confirmed through an alternative method to ensure compliance with state and federal laws.
Limitations
The test only provides a preliminary screening result and should not be used as the sole evidence in diagnostic or forensic settings. Confirmatory testing is required for positive findings, and interference from certain medications or adulterants may cause inaccurate results. The test does not meet forensic urine drug testing program requirements.
Methodology
Immunoassay (ELISA)
Biomarkers
LOINC Codes
- 6799-1
- 8251-1
Result Turnaround Time
2-5 days
Related Documents
For more information, please review the documents below
Specimen
Urine
Volume
30 mL
Minimum Volume
Not provided
Container
Urine container
Storage Instructions
Maintain specimen at room temperature. If arrival at lab will extend beyond seven days, refrigerate.
Other tests from different labs that may be relevant